Walder Wyss advised +ND Capital and the other sellers in the transaction. Novartis has acquired Arctos Medical, adding a pre-clinical optogenetics-based AAV gene therapy program and...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised lead investor Revaia on the deal. Wenger Vieli advised Frontify. Frontify AG, a leading provider of brand management software, raised an additional USD...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey advised Invision on the deal. Walder Wyss advised Evoco AG. Invision, a leading investment company focused on succession solutions and growth financing in...
You must be a Standard 1 Year member to access this content.
Paul Hastings advised J.P. Morgan and Barclays Bank PLC on the deal. Walder Wyss and DLA Piper advised MKS Instruments. MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”),...
You must be a Standard 1 Year member to access this content.
Walder Wyss AG acted as Swiss counsel to Nordic Infrastructure AG. Solör Bioenergy Group´s main shareholder Nordic Infrastructure AG (NIAG) successfully completed a EUR 200m Green...
You must be a Standard 1 Year member to access this content.
CMS advised the shareholders of Quartal on all legal matters of the transaction. Walder Wyss Ltd. advised PureFacts Financial Solutions. McCarthy Tétrault LLP advised The Bank...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acted as Swiss legal advisor to EMZ in this transaction, with Walder Wyss. CMS advised the shareholders of ASSEPRO and its management on...
You must be a Standard 1 Year member to access this content.
